Breen Doron
CIK 0001496203 Name as filed on the most recent filing
Filed as Breen Doron (14)
83 transaction lines · from 14 filings · filed 2010-07-29 to 2011-08-11 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2011-08-10 |
NeurogesX Inc NGSX |
S, Open-market sale | 82,109 disposed | 2.00 | 164,571.07 | Form 4, filing 0001178913-11-002266 | |
| 2011-08-09 |
NeurogesX Inc NGSX |
S, Open-market sale | 81,359 disposed | 2.15 | 175,174.06 | Form 4, filing 0001178913-11-002266 | |
| 2011-06-27 |
NeurogesX Inc NGSX |
S, Open-market sale | 1,079 disposed | 2.10 | 2,270.65 | Form 4, filing 0001178913-11-001808 | |
| 2011-06-24 |
NeurogesX Inc NGSX |
S, Open-market sale | 7,499 disposed | 2.10 | 15,753.15 | Form 4, filing 0001178913-11-001808 | |
| 2011-06-23 |
NeurogesX Inc NGSX |
S, Open-market sale | 50,000 disposed | 2.09 | 104,535.00 | Form 4, filing 0001178913-11-001798 | |
| 2011-06-16 |
NeurogesX Inc NGSX |
S, Open-market sale | 80,192 disposed | 2.95 | 236,438.09 | Form 4, filing 0001178913-11-001791 | |
| 2011-06-16 |
NeurogesX Inc NGSX |
S, Open-market sale | 300,000 disposed | 3.20 | 961,380.00 | Form 4, filing 0001178913-11-001791 | |
| 2011-06-16 |
NeurogesX Inc NGSX |
S, Open-market sale | 18,810 disposed | 2.95 | 55,459.40 | Form 4, filing 0001178913-11-001791 | |
| 2011-06-16 |
NeurogesX Inc NGSX |
S, Open-market sale | 300,000 disposed | 3.20 | 961,380.00 | Form 4, filing 0001178913-11-001765 | |
| 2011-06-16 |
NeurogesX Inc NGSX |
S, Open-market sale | 80,192 disposed | 2.95 | 236,438.09 | Form 4, filing 0001178913-11-001765 | |
| 2011-06-16 |
NeurogesX Inc NGSX |
S, Open-market sale | 18,810 disposed | 2.95 | 55,459.40 | Form 4, filing 0001178913-11-001765 | |
| 2011-06-03 |
NeurogesX Inc NGSX |
S, Open-market sale | 3,300 disposed | 2.22 | 7,326.00 | Form 4, filing 0001178913-11-001665 | |
| 2011-06-02 |
NeurogesX Inc NGSX |
S, Open-market sale | 14,425 disposed | 2.36 | 34,100.70 | Form 4, filing 0001178913-11-001665 | |
| 2011-06-02 |
NeurogesX Inc NGSX |
S, Open-market sale | 3,382 disposed | 2.36 | 7,995.05 | Form 4, filing 0001178913-11-001665 | |
| 2011-06-01 |
NeurogesX Inc NGSX |
S, Open-market sale | 8,910 disposed | 2.46 | 21,889.20 | Form 4, filing 0001178913-11-001639 | |
| 2011-06-01 |
NeurogesX Inc NGSX |
S, Open-market sale | 2,090 disposed | 2.46 | 5,134.50 | Form 4, filing 0001178913-11-001639 | |
| 2011-03-28 |
NeurogesX Inc NGSX |
S, Open-market sale | 9,853 disposed | 4.07 | 40,110.58 | Form 4, filing 0001178913-11-000930 | |
| 2011-03-28 |
NeurogesX Inc NGSX |
S, Open-market sale | 2,463 disposed | 4.07 | 10,026.63 | Form 4, filing 0001178913-11-000930 | |
| 2011-03-24 |
NeurogesX Inc NGSX |
S, Open-market sale | 120,000 disposed | 4.02 | 482,940.00 | Form 4, filing 0001178913-11-000895 | |
| 2011-03-24 |
NeurogesX Inc NGSX |
S, Open-market sale | 32,600 disposed | 4.07 | 132,610.28 | Form 4, filing 0001178913-11-000895 | |
| 2011-03-23 |
NeurogesX Inc NGSX |
S, Open-market sale | 17,575 disposed | 4.00 | 70,379.09 | Form 4, filing 0001178913-11-000877 | |
| 2011-03-23 |
NeurogesX Inc NGSX |
S, Open-market sale | 12,100 disposed | 4.01 | 48,536.73 | Form 4, filing 0001178913-11-000877 | |
| 2011-03-23 |
NeurogesX Inc NGSX |
S, Open-market sale | 4,125 disposed | 4.00 | 16,518.56 | Form 4, filing 0001178913-11-000877 | |
| 2011-03-01 |
NeurogesX Inc NGSX |
S, Open-market sale | 6,806 disposed | 3.53 | 24,048.32 | Form 4, filing 0001178913-11-000645 | |
| 2011-03-01 |
NeurogesX Inc NGSX |
S, Open-market sale | 1,494 disposed | 3.53 | 5,278.90 | Form 4, filing 0001178913-11-000645 | |
| 2011-02-28 |
NeurogesX Inc NGSX |
S, Open-market sale | 5,808 disposed | 3.87 | 22,453.15 | Form 4, filing 0001178913-11-000645 | |
| 2010-07-12 |
Orexigen Therapeutics, Inc. OREX |
S, Open-market sale | 20,000 disposed | 4.15 | 82,990.00 | Form 4, filing 0001178913-10-002137 | |
| 2010-07-01 |
NeurogesX Inc NGSX |
P, Open-market purchase | 4,100 acquired | 6.39 | 26,197.36 | Form 4, filing 0001178913-10-001955 | |
| 2010-06-30 |
NeurogesX Inc NGSX |
P, Open-market purchase | 10,501 acquired | 6.65 | 69,850.55 | Form 4, filing 0001178913-10-001955 | |
| 2010-06-28 |
NeurogesX Inc NGSX |
P, Open-market purchase | 7,000 acquired | 7.16 | 50,150.10 | Form 4, filing 0001178913-10-001955 | |
| 2010-05-04 |
NeurogesX Inc NGSX |
P, Open-market purchase | 5,217 acquired | 9.94 | 51,862.72 | Form 4, filing 0001178913-10-001955 | |
| 2010-03-31 |
NeurogesX Inc NGSX |
P, Open-market purchase | 12,000 acquired | 9.44 | 113,328.00 | Form 4, filing 0001178913-10-001955 | |
| 2010-03-29 |
NeurogesX Inc NGSX |
P, Open-market purchase | 8,000 acquired | 9.51 | 76,082.40 | Form 4, filing 0001178913-10-001955 | |
| 2010-02-10 |
NeurogesX Inc NGSX |
P, Open-market purchase | 33,700 acquired | 7.28 | 245,278.71 | Form 4, filing 0001178913-10-001955 | |
| 2010-02-10 |
NeurogesX Inc NGSX |
P, Open-market purchase | 10,000 acquired | 7.26 | 72,583.00 | Form 4, filing 0001178913-10-001955 | |
| 2010-02-09 |
NeurogesX Inc NGSX |
P, Open-market purchase | 2,000 acquired | 7.20 | 14,404.80 | Form 4, filing 0001178913-10-001955 | |
| 2010-02-09 |
NeurogesX Inc NGSX |
P, Open-market purchase | 500 acquired | 7.20 | 3,601.20 | Form 4, filing 0001178913-10-001955 | |
| 2010-01-29 |
NeurogesX Inc NGSX |
P, Open-market purchase | 5,521 acquired | 7.06 | 38,995.38 | Form 4, filing 0001178913-10-001955 | |
| 2010-01-07 |
NeurogesX Inc NGSX |
P, Open-market purchase | 2,500 acquired | 7.09 | 17,729.50 | Form 4, filing 0001178913-10-001955 | |
| 2010-01-04 |
NeurogesX Inc NGSX |
P, Open-market purchase | 5,000 acquired | 7.66 | 38,318.00 | Form 4, filing 0001178913-10-001955 | |
| 2009-12-31 |
NeurogesX Inc NGSX |
P, Open-market purchase | 2,400 acquired | 7.81 | 18,735.12 | Form 4, filing 0001178913-10-001955 | |
| 2009-12-30 |
NeurogesX Inc NGSX |
P, Open-market purchase | 2,500 acquired | 7.60 | 19,010.75 | Form 4, filing 0001178913-10-001955 | |
| 2009-12-29 |
NeurogesX Inc NGSX |
P, Open-market purchase | 3,100 acquired | 7.37 | 22,847.31 | Form 4, filing 0001178913-10-001955 | |
| 2009-12-14 |
NeurogesX Inc NGSX |
P, Open-market purchase | 3,600 acquired | 7.82 | 28,137.96 | Form 4, filing 0001178913-10-001955 | |
| 2009-12-11 |
NeurogesX Inc NGSX |
P, Open-market purchase | 5,600 acquired | 7.79 | 43,646.96 | Form 4, filing 0001178913-10-001955 | |
| 2009-12-10 |
NeurogesX Inc NGSX |
P, Open-market purchase | 8,000 acquired | 7.76 | 62,072.80 | Form 4, filing 0001178913-10-001955 | |
| 2009-12-09 |
NeurogesX Inc NGSX |
P, Open-market purchase | 10,000 acquired | 7.44 | 74,448.00 | Form 4, filing 0001178913-10-001955 | |
| 2009-12-08 |
NeurogesX Inc NGSX |
P, Open-market purchase | 7,600 acquired | 7.55 | 57,363.28 | Form 4, filing 0001178913-10-001955 | |
| 2009-12-07 |
NeurogesX Inc NGSX |
P, Open-market purchase | 8,000 acquired | 7.53 | 60,224.00 | Form 4, filing 0001178913-10-001955 | |
| 2009-12-04 |
NeurogesX Inc NGSX |
P, Open-market purchase | 35,000 acquired | 7.89 | 276,290.00 | Form 4, filing 0001178913-10-001955 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. BREEN DORON, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001496203
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6